Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy

Despite significant advances in cystic fibrosis (CF) treatments, a one-time treatment for this life-shortening disease remains elusive. Stable complementation of the disease-causing mutation with a normal copy of the CF transmembrane conductance regulator (CFTR) gene fulfills that goal. Integrating...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez Loza, Laura I., Cooney, Ashley L., Dong, Qian, Randak, Christoph O., Rivella, Stefano, Sinn, Patrick L., McCray, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973238/
https://www.ncbi.nlm.nih.gov/pubmed/33768133
http://dx.doi.org/10.1016/j.omtm.2021.02.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973238/
https://www.ncbi.nlm.nih.gov/pubmed/33768133
http://dx.doi.org/10.1016/j.omtm.2021.02.020

Ejemplares similares